RESNIBEN
"RESNIBEN" is a word mark owned by Azurity Pharmaceuticals, Inc., filed at the USPTO on April 30, 2025. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since October 5, 2026
- Filed
- April 30, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99163806
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns RESNIBEN
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Azurity Pharmaceuticals, Inc.
Woburn, United States
Representative
Douglas R. Wolf
Wolf Greenfield & Sacks, P.C.
What the mark covers
The products and services RESNIBEN is filed for, grouped by Nice class.
pharmaceutical preparations for the treatment of cancer, pain, infection, inflammation, hormone disorders, bone disorders, and mental disorders; analgesics; hormones; psychotropics; anti-infectives; anti-inflammatories; anti-cancer preparations
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 2 granted
- Sou extension 2 filed
- Sou teas extension received
- Notice of approval of extension request e-mailed
- Sou extension 1 granted
- Sou extension 1 filed
- Sou teas extension received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
7 earlier steps on the official record.
About RESNIBEN
Who owns the trademark "RESNIBEN"?
The USPTO trademark "RESNIBEN" (application 99163806) is owned by Azurity Pharmaceuticals, Inc.
What is the status of "RESNIBEN"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull RESNIBEN and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2abb-f3f5-74b3-8685-ae88df5bd795
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2abb-f3f5-74b3-8685-ae88df5bd795",
"object": "trademark",
"mark_text": "RESNIBEN",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99163806",
"filing_date": "2025-04-30",
"nice_classes": [
5
],
"owners": [
{
"name": "Azurity Pharmaceuticals, Inc.",
"entity_id": "ent_019eb725-e6a7-73db-81c8-7bbc8473b1bf"
}
]
}